The word “Amicogen” consists of the meaning of friend, “AMICO”
in Latin and of gene, “GENE”. We developed innovative biocatalysts
and proteins by applying our proprietary i DNA Evolution™ Technology.
We are a “Bioengineering company just like a Sincere Friend”
who contributes to the human health and the preservation of environment.
Amicogen Biotech R&D Center is expanding its R&D field based on
bio-platform technology, and researchers account for 30% of all employees.
We will lead the Industrial Biotechnology to develop new technologies
that can drive the development of humanity and society,
one step further than others.
Amicogen has developed Special Enzymes for industrial and pharmaceutical products based on the i DNA evolution™.
We want to contribute to the sustainable growth and lifelong health
of humanity by developing New Bio-Ingredientfor Health functional foods
with Special Enzymes and Protein Purification Resin.
As Amicogen started as a bio-venture company, we have focused on
the core competence of R&D and are pursuing sustainable growth
in innovative technologies and products. To increase the value
of enterprise and shareholder, we are continually strengthening our core competencies such as specialty enzyme business, healthcare, protein
purification resin business and others.
Amicogen promotes various activities to realize the value of contributing
to the protection of human health and the environment.
Amicogen is positioning itself as a global biotechnology company
through growth and leaps to create new values.
Amicogen has developed bio innovative technologies and operated the businesses that consider humankind and environment from the perspective of sustainability for the past 20 years. We will continue sustainable development based on Amicogen's environmental soundness, social responsibility and sustainable innovative technology.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen will try our best to maximize our shareholders' value
and realize the full potential of the company.
2023-11-29
신주발행 공고
아미코젠 주식회사 주주 여러분께
신주발행 공고
2023년 09월 15일에 개최한 아미코젠 주식회사 이사회에서 아래와 같이 준비금의 자본전입에 따른 신주 발행을 결의하였음을 공고합니다.
- 아 래 -
1. 자본에 전입한 금액과 재원 : 주식발행초과금 13,626,289,500원
2. 자본전입에 따른 신주 발행에 관한 사항
⑴ 주식의 종류 : 기명식 보통주식
⑵ 발행주식수 : 27,252,579주
⑶ 발행금액 : 13,626,289,500원
⑷ 주식의 액면가액 : 1주당 500원
⑸ 신주 배정기준일 : 2023년 12월 14일
⑹ 신주 배당기산일 : 2023년 01월 01일
⑺ 신주 배정방법 및 단주 처리
2023년 12월 14일 18시 현재 주주명부에 등재된 주주에 대하여 소유주식 1주당 100.000000%의 비율로 신주를 배정함. 다만, 1주 미만의 단주에 대해서는 신주배정기 준일 또는 상장초일 종가를 기준으로 매각하여 현금으로 지급함.
⑻ 신주 유통(상장)예정일 : 2024년 01월 05일
경상남도 진주시 문산읍 월아산로950번길 14-10
아미코젠 주식회사 대표이사 표 쩌
명의개서대리인 한국예탁결제원 사장 이 순 호
2023년 11월 29일